STP02-3725

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameSTP02-3725
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThrombin inhibitors
TargetsProthrombin
Therapy Area/IndicationsVenous ThrombosisThrombosisAtrial Fibrillation +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSt Pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSt Pharm Co Ltd
Active IndicationsN/A
Inactive IndicationsVenous ThrombosisThrombosisAtrial Fibrillation +[4] 

Other Information

ATC CodeN/A
Related LinksN/A